Advanced Autologous TIL Manufacturing
Our focus on developing next generation process for TIL manufacturing for immunotherapies have resulted in significant improvements to the process that are now available for your projects:
We have developed a cutting-edge TIL manufacturing process that significantly cuts down the cost and time for TIL manufacturing
Using our next generation platform, we can manufacture TIL products for your immunotherapy studies in a short time frame
We can further test your TIL products for efficacy using our organoid platform/cytotoxicity assays
Using our platform, you can substantially speed up your TIL product development for TIL studies
Deliverable: TIL product produced per client specification in a short time frame with significant savings
Tumor Organoids for
Oncology Drug Development
We routinely grow organoids for our own oncology cell therapy clinical studies, and this has allowed our team to gain substantial experience in developing a robust and streamlined organoid platform. Using this platform, our Experienced Organoid team can streamline your organoid development
Growing tumor cells is time-consuming and labor intensive
Using our organoid platform, our experienced team can quickly start growing your desired tumor cells for your research and development needs
Organoids can be grown using your tumor samples or using our extensive catalog of tumor samples from a variety of cancer indications depending on your needs
Depending on the starting tumor material, organoids can be ready for assays within 2-6 weeks
We can further carry out co-culture assays with both autologous and non-autologous immune cells on the tumor cells to progress your immunotherapy drug discovery
Using our customized services, you can significantly speed up your oncology drug development while we handle all of your organoid needs from tumor sample procurement to testing your product on the organoid depending on your needs
In addition, as part of our informatics services, we provide single cell sequencing and data rich analysis of the final tumor organoids to further enhance your project and provide the data you need
Deliverable: Rapid cultivation of primary tumor cells in a cost-effective manner; additional co-culture assays using these organoids also available to provide a one-stop and cost-effective solution
